Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Celecoxib's effect on inflammatory response in patients receiving thoracic and abdominal surgery (Phase II study)

Next Previous
Trial Profile

Celecoxib's effect on inflammatory response in patients receiving thoracic and abdominal surgery (Phase II study)

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 23 Jan 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Celecoxib (Primary)
  • Indications Inflammation
  • Focus Therapeutic Use

    • Most Recent Events

    • 13 Jan 2017 Primary endpoint has not been met. (Urine prostaglandin E metabolite at 48 hours following surgery commencement as measured by immunoassay), as per the results published in the Canadian Journal of Anesthesia.
    • 13 Jan 2017 Primary endpoint has not been met. (Plasma prostaglandin E metabolite at 48 hours following surgery commencement as measured by immunoassay), as per the results published in the Canadian Journal of Anesthesia.
    • 13 Jan 2017 Results published in the Canadian Journal of Anesthesia.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top